These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17379074)

  • 1. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
    Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
    Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).
    Schichor C; Birnbaum T; Etminan N; Schnell O; Grau S; Miebach S; Aboody K; Padovan C; Straube A; Tonn JC; Goldbrunner R
    Exp Neurol; 2006 Jun; 199(2):301-10. PubMed ID: 16574102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells regulate angiogenesis according to their mechanical environment.
    Kasper G; Dankert N; Tuischer J; Hoeft M; Gaber T; Glaeser JD; Zander D; Tschirschmann M; Thompson M; Matziolis G; Duda GN
    Stem Cells; 2007 Apr; 25(4):903-10. PubMed ID: 17218399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing.
    Neuss S; Becher E; Wöltje M; Tietze L; Jahnen-Dechent W
    Stem Cells; 2004; 22(3):405-14. PubMed ID: 15153617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin.
    Danielyan L; Schäfer R; Schulz A; Ladewig T; Lourhmati A; Buadze M; Schmitt AL; Verleysdonk S; Kabisch D; Koeppen K; Siegel G; Proksch B; Kluba T; Eckert A; Köhle C; Schöneberg T; Northoff H; Schwab M; Gleiter CH
    Cell Death Differ; 2009 Dec; 16(12):1599-614. PubMed ID: 19609278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of erythropoietin in regulating angiogenesis.
    Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
    Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia.
    Li L; Okada H; Takemura G; Esaki M; Kobayashi H; Kanamori H; Kawamura I; Maruyama R; Fujiwara T; Fujiwara H; Tabata Y; Minatoguchi S
    J Am Coll Cardiol; 2009 Jun; 53(25):2378-88. PubMed ID: 19539150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways.
    Du G; Zhu H; Yu P; Wang H; He J; Ye L; Fu F; Zhang J; Tian J
    Eur J Pharmacol; 2013 Jan; 700(1-3):173-80. PubMed ID: 23276662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells.
    Ashley RA; Dubuque SH; Dvorak B; Woodward SS; Williams SK; Kling PJ
    Pediatr Res; 2002 Apr; 51(4):472-8. PubMed ID: 11919332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.
    Potapova IA; Gaudette GR; Brink PR; Robinson RB; Rosen MR; Cohen IS; Doronin SV
    Stem Cells; 2007 Jul; 25(7):1761-8. PubMed ID: 17395769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
    Li Y; Lu Z; Keogh CL; Yu SP; Wei L
    J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation.
    Ozawa T; Toba K; Kato K; Minagawa S; Saigawa T; Hanawa H; Makiyama Y; Moriyama M; Honma K; Isoda M; Hasegawa G; Naito M; Takahashi M; Aizawa Y
    J Mol Cell Cardiol; 2006 May; 40(5):629-38. PubMed ID: 16603182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
    Yamada J; Tsuno NH; Kitayama J; Tsuchiya T; Yoneyama S; Asakage M; Okaji Y; Shuno Y; Nishikawa T; Tanaka J; Takahashi K; Nagawa H
    J Surg Res; 2009 Jan; 151(1):115-20. PubMed ID: 18619615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.